Titanium brush
Devicea titanium brush will be tested as mechanical decontamination in regenerative treatment of peri-implantitis
NCT Number: NCT03512730
Objective:
The objective of this study was to evaluate a new mechanical method (Ti-Brush, Straumann, AG, Basel, Switzerland) of implant surface decontamination.
Material and methods:
A randomized double-blinded controlled clinical trial with a 1-year follow-up it is being carried out. After a hygienic phase, defects were randomly assigned to a control (n=18) or to a test group (n=18). In control group, implant surface was decontaminated both mechanically and chemically with 3% H2O2 and plastic ultrasonic scalers, respectively, while in test group Ti-Brush was added. Infrabony defects in both groups were regenerated with BoneCeramic (Straumann, AG, Basel Switzerland) and collagen barrier membrane Cytoplast (Osteogenics, Lubbock, United States). Clinical and radiographic parameters were measured at baseline, 6, and 12 months after surgery.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Phase 2
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a titanium brush will be tested as mechanical decontamination in regenerative treatment of peri-implantitis
Classic decontamination will be performed by means of H2O2 3% and plastic curettes
Time frame: 6 and 12 months
Universitat Internacional de Catalunya
Other
BENEFITS OF A NEW MECHANICAL DECONTAMINATION METHOD, TI-BRUSH, ON THE ADJUNCT TREATMENT OF REGENERATIVE THERAPY OF PERI-IMPLANTITIS LESIONS: 12-MONTH OUTCOMES OF A RANDOMIZED CONTROLLED CLINICAL TRIAL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06083246
Mouth Diseases, Peri-Implantitis
Pavia, Lombardy, Italy
View Trial DetailsNCT05024760
Dental Implant Failed, Implant Infection
Tacoma, Washington, United States
View Trial DetailsNCT07700628
Mouth Diseases, Peri-Implantitis
Caserta, CE, Italy
View Trial DetailsNCT07678892
Mouth Diseases, Peri-Implantitis
Kristianstad, Sweden
View Trial Details